One such mechanism may involve the obesity-related state of chronic low-grade inflammation, as indicated by biomarkers such as c-reactive protein (CRP) and interleukin-6 (IL-6). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.